Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Amicus Therapeutics
LEI 549300MRD1SMUTNBPQ53

Nom de l'organisation
Amicus Therapeutics, Inc.
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
-

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases.

Récompenses

Actualités

28/02/2024 Amicus Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
07/01/2024 Amicus Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
02/12/2023 Amicus Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements S Of Certain Officers, Financial Statements And Exhibits
05/10/2023 Amicus Therapeutics: Termination Of A Material Definitive Agreement, Financial Statements And Exhibits
02/10/2023 Amicus Therapeutics: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    549300MRD1SMUTNBPQ53
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001178879
  • EIN
    20-0422823

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.